Thalidomide-associated hypothyroidism in a patient with multiple myeloma

[Rinshō ketsueki] The Japanese journal of clinical hematology
Ikue OkamuraFumihiko Kimura

Abstract

Thalidomide is highly effective against multiple myeloma, but some patients must discontinue this medication due to adverse effects. We present herein an instructive case report on thalidomide-associated hypothyroidism in a patient with multiple myeloma. Thyroid hormone replacement therapy allowed us to restart administration of thalidomide, a potentially life-saving therapy. Known adverse effects of thalidomide, such as lethargy, constipation, and bradycardia, are potential symptoms of hypothyroidism, but we tend to overlook drug-associated hypothyroidism. Our case highlights the importance of routinely testing thyroid function in patients receiving thalidomide therapy.

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Related Papers

The Annals of Pharmacotherapy
Michiel DuyvendakJacobus R B J Brouwers
The New England Journal of Medicine
Judah Folkman, Michael S Rogers
The New England Journal of Medicine
Y KishiU Machida
© 2022 Meta ULC. All rights reserved